Related Experiment Video
Updated: Jun 21, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Endothelial cell loss post-implantable collamer lens V4c: meta-analysis
Filip Blazej Kisiel1, Gerard Jonathan Gurumurthy
1From the Department of Chemical Engineering, University of Manchester, Manchester, United Kingdom (Kisiel); Department of Medicine, University of Manchester, Manchester, United Kingdom (Gurumurthy).
Endothelial cell density loss after implantable collamer lens (ICL) V4c surgery for myopia is most significant in the first three months. This meta-analysis confirms ICL V4c safety, showing comparable cell loss to other ICL models.
Area of Science:
- Ophthalmology
- Biomaterials Science
Background:
- Endothelial cell density (ECD) loss is a known complication of implantable collamer lens (ICL) V4c surgery for myopia correction.
- Existing literature presents varied ECD loss data, complicating patient and clinician guidance.
Approach:
- A meta-analysis was conducted on 18 studies evaluating ECD loss following ICL V4c implantation.
- Subgroup analyses were performed based on follow-up durations to address data variability.
Key Points:
- Average ECD loss was 1.32% at 3 months, 1.75% at 12 months, and 3.84% at a mean of 21.25 months post-surgery.
- The most substantial ECD loss occurred within the initial 3 months, indicating acute surgical trauma as the primary factor.
- ECD loss with ICL V4c is comparable to other ICL models, suggesting consistent safety profiles.
Conclusions:
- ICL V4c surgery for myopia correction demonstrates a predictable pattern of endothelial cell density loss.
- The findings affirm the overall safety of the ICL V4c model in terms of endothelial cell health.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

